Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France

Completed

• Conditions: Healthy

• Registration Number: NCT01211652
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to assess in general population NSAID and gastroprotective agent utilization and compliance in elderly people.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-09-20
• Study First Submitted QC: 2010-09-28
• Study First Posted: 2010-09-29
• Study Start: 2010-10
• Primary Completion: 2010-11
• Study Completion: 2010-11
• Status Verified: 2013-01
• Last Update Submitted: 2013-01-28
• Last Update Posted: 2013-01-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 8186

Inclusion Criteria

• French people > 65 years old, part of Kantar Health Access Santé panel

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
NSAID Treatment Compliance	At the end of month 1
Gastroprotective agent compliance (Girerd Questionnaire)	At the end of month 1

Trial Locations

Locations (1)

Research Site; 🇫🇷 Yzeure, France